| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035049 |
| Receipt No. | R000039956 |
| Official scientific title of the study | Effect of L-citrulline intake on exercise performance and fatigue in student athletes |
| Date of disclosure of the study information | 2018/11/28 |
| Last modified on | 2018/11/28 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Effect of L-citrulline intake on exercise performance and fatigue in student athletes | |
| Title of the study (Brief title) | Effect of L-citrulline intake on exercise performance | |
| Region |
|
|
| Condition | ||
| Condition | Healthy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the effect of short-term low-dose L-citrulline intake on short-time high-intensity exercise performance in student athletes |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | power output by bicycle ergometer, rate of perceived exertion, and amount of nitric oxide in blood after L-citrulline intake for 7 days |
| Key secondary outcomes | VO2, VCO2, carbohydrate oxidation, Fat oxidation, heart rate, blood pressure, lactic acid, white blood cell count, red blood cell count, hemoglobin, hematocrit, creatine phosphokinase, serum glucose, ammonia |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1) blood sampling, heart rate and blood pressure measurement before exercise
2) short-time high-intensity exercise (Wingate test) 3) blood lactic acid and RPE measurement during exercise 4) blood sampling, heart rate and blood pressure measurement after exercise |
|
| Interventions/Control_2 | 1) L-citrulline or placebo intake of 3 g/day for 7 days
2) blood sampling, heart rate and blood pressure measurement before exercise 3) short-time high-intensity exercise (Wingate test) 4) blood lactic acid and RPE measurement during exercise 5) blood sampling, heart rate and blood pressure measurement after exercise |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Japanese healthy male students at Kanazawa University who were members of the university track team and specialized mainly in middle-distance running participated | |||
| Key exclusion criteria | participants who take nutritional supplements containing L-citrulline, Arginine, ornithine, glutamine, creatine, and branched chain amino acids (BCAA) regularly, or ingest large quantities of watermelon or other types of melon for the duration of the experiment | |||
| Target sample size | 9 | |||
| Research contact person | |
| Name of lead principal investigator | Naoko Terasawa |
| Organization | Kanazawa University |
| Division name | Faculty of Human Science |
| Address | Kakuma, Kanazawa |
| TEL | 076-264-5484 |
| terasawa@staff.kanazawa-u.ac.jp | |
| Public contact | |
| Name of contact person | Naoko Terasawa |
| Organization | Kanazawa University |
| Division name | Faculty of Human Science |
| Address | Kakuma, Kanazawa |
| TEL | 076-264-5484 |
| Homepage URL | |
| terasawa@staff.kanazawa-u.ac.jp | |
| Sponsor | |
| Institute | Kanazawa University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kanazawa University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039956 |